Literature DB >> 30010613

Validating a Monte Carlo approach to absolute dose quality assurance for proton pencil beam scanning.

C Winterhalter1, E Fura, Y Tian, A Aitkenhead, A Bolsi, M Dieterle, A Fredh, G Meier, D Oxley, D Siewert, D C Weber, A Lomax, S Safai.   

Abstract

For radiotherapy, it is crucial to guarantee that the delivered dose matches the planned dose. Therefore, patient specific quality assurance (QA) of absolute dose distributions is necessary. Here, we investigate the potential of replacing patient specific QA for pencil beam scanned proton therapy with Monte Carlo simulations. First, the set-up of the automated Monte Carlo model is presented with an emphasis on the absolute dose validation. Second, the absolute dose results obtained from the Monte Carlo simulation for a comprehensive set of patient fields are compared to patient specific QA measurements. Absolute doses measured with the Farmer chamber are shown to be 1.4% higher than the doses measured with the Semiflex chamber. For single energy layers, Monte Carlo simulated doses are 2.1%  ±  0.4% lower than the ones measured with the ionization chamber and 1.1%  ±  1.0% lower than measurements compared to patient field verification measurements. After rescaling to account for this 1.1% discrepancy, 98 fields (94.2%) agree within 2% to measurements, the maximum difference being 2.3%. In conclusion, an automated, easy-to-use Monte Carlo calculation system has been set up. This system reproduced patient specific QA results over a wide range of cases, showing that the time consuming measurements could be reduced or even replaced using Monte Carlo simulations without jeopardizing treatment quality.

Entities:  

Mesh:

Year:  2018        PMID: 30010613     DOI: 10.1088/1361-6560/aad3ae

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  7 in total

1.  DICOM-RT Ion interface to utilize MC simulations in routine clinical workflow for proton pencil beam radiotherapy.

Authors:  Jungwook Shin; Hanne M Kooy; Harald Paganetti; Benjamin Clasie
Journal:  Phys Med       Date:  2020-05-07       Impact factor: 2.685

2.  Improved simultaneous LET and dose measurements in proton therapy.

Authors:  Jeppe Brage Christensen; Michele Togno; Lily Bossin; Oskari Ville Pakari; Sairos Safai; Eduardo Gardenali Yukihara
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

3.  Transitioning from measurement-based to combined patient-specific quality assurance for intensity-modulated proton therapy.

Authors:  Mei Chen; Pablo Yepes; Yoshifumi Hojo; Falk Poenisch; Yupeng Li; Jiayi Chen; Cheng Xu; Xiaodong He; G Brandon Gunn; Steven J Frank; Narayan Sahoo; Heng Li; Xiaorong Ronald Zhu; Xiaodong Zhang
Journal:  Br J Radiol       Date:  2019-12-16       Impact factor: 3.039

4.  Pitfalls in the beam modelling process of Monte Carlo calculations for proton pencil beam scanning.

Authors:  Carla Winterhalter; Adam Aitkenhead; David Oxley; Jenny Richardson; Damien C Weber; Ranald I MacKay; Antony J Lomax; Sairos Safai
Journal:  Br J Radiol       Date:  2020-02-06       Impact factor: 3.039

5.  Benchmarking a commercial proton therapy solution: The Paul Scherrer Institut experience.

Authors:  Sara Rosas; Francesca M Belosi; Nicola Bizzocchi; Till Böhlen; Stefan Zepter; Petra Morach; Antony J Lomax; Damien C Weber; Jan Hrbacek
Journal:  Br J Radiol       Date:  2020-01-30       Impact factor: 3.039

6.  Automated Monte-Carlo re-calculation of proton therapy plans using Geant4/Gate: implementation and comparison to plan-specific quality assurance measurements.

Authors:  Adam H Aitkenhead; Peter Sitch; Jenny C Richardson; Carla Winterhalter; Imran Patel; Ranald I Mackay
Journal:  Br J Radiol       Date:  2020-07-29       Impact factor: 3.039

Review 7.  Roadmap: proton therapy physics and biology.

Authors:  Harald Paganetti; Chris Beltran; Stefan Both; Lei Dong; Jacob Flanz; Keith Furutani; Clemens Grassberger; David R Grosshans; Antje-Christin Knopf; Johannes A Langendijk; Hakan Nystrom; Katia Parodi; Bas W Raaymakers; Christian Richter; Gabriel O Sawakuchi; Marco Schippers; Simona F Shaitelman; B K Kevin Teo; Jan Unkelbach; Patrick Wohlfahrt; Tony Lomax
Journal:  Phys Med Biol       Date:  2021-02-26       Impact factor: 4.174

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.